ロード中...

Systemic administration of β(2)-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses

1. β(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by β(1)-adrenoceptor activation. 2. Two β(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an ex...

詳細記述

保存先:
書誌詳細
主要な著者: Ryall, James G, Sillence, Martin N, Lynch, Gordon S
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2006
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1751341/
https://ncbi.nlm.nih.gov/pubmed/16432501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706669
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!